SARS-CoV-2 Lin. BQ.1.3; Omicron Var. (USA/NY-Wadsworth-22047869-01/2022) CF (HI) (1 mL)
- Volume: 1.0mL
- Units/Pack: 1
- Storage Condition: -65°C or below
- Hazardous Information: Non-Infectious
Description
SARS-Related Coronavirus 2 Lineage BQ.1.3; Omicron Variant (Isolate: USA/NY-Wadsworth-22047869-01/2022) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus.
SARS-CoV-2 isolate USA/NY-Wadsworth-22047869-01/2022 was collected in September 2022 in New York, USA. Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA/NY-Wadsworth-22047869-01/2022 is assigned lineage BQ.1.3. The complete genome of USA/NY-Wadsworth-22047869-01/2022 has been sequenced (GISAID: EPI_ISL_15490996).
Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot.
Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.